TP53 and breast cancer: We applied a combination of molecular, genetic and pharmacologic manipulations, as well as different biochemical and cell imaging analyses in vitro and mouse models, to investigate the role of Kindlin-2 in modulating the p53-mediated regulation of senescence in BC.